Introduction
The coumarin nucleus is frequently found in bioactive compounds and plays an important role in biochemical processes. The cytotoxic activities of the coumarin derivatives were tested in several human tumor cell lines [1] [2] [3] [4] [5] [6] [7] . In addition, the antimicrobial, antitumor, anti-inflammatory, antimalarial and anti-HIV activities of hydrazide compounds on tumor cell lines have been observed and recently reported [8] [9] [10] [11] [12] [13] [14] , Moreover, some synthetic oxadiazole derivatives exhibit a range of pharmacological activities [15] [16] [17] [18] . The biological and medicinal activities of triazole moieties have stimulated considerable interest in the synthesis of derivatives of this ring system [19] [20] [21] [22] [23] [24] [25] . In view of the above observations and in continuation of our previous works in heterocyclic chemistry, we report herein the synthesis of some new derivatives of these ring systems incorporated with 4-phenylcoumarin moiety, using ethyl 2-(2-oxo-4-phenyl-2H-chromen-7-yloxy) acetate (1) [26] as a key starting material. A selected series of these compounds were investigated for their antitumor activities.
Experimental

Instrumentation
All melting points, antioxidant and anticancer activities are uncorrected. IR spectra (KBr) were recorded on FT-IR 5300 spectrometer and Perkin Elmer spectrum RXIFT-IR system (ν, cm -1 ). The 1 H NMR spectra were recorded in (DMSO-d6) at 300 MHz on a Varian Mercury VX-300 NMR spectrometer (δ, ppm) using TMS as an internal standard. 13 C NMR spectra were recorded on Varian Mercury VX 300 NMR using DMSO-d6 as solvent and TMS as an internal standard. Mass spectrum was obtained on GC MS-QP 1000 EX mass spectrometer at 70 eV. Elemental analyses were carried out by the Microanalytical Research Center, Faculty of Science, Cairo University and AlAzhar University.
Scheme 1
Synthesis
Synthesis of 2-(2-oxo-4-phenyl-2H-chromen-7-yloxy) acetohydrazide (2)
A mixture of compound 1 (0.01 mol) and hydrazine hydrate (0.02 mol) in ethanol (30 mL) was refluxed for 8 h. 
Synthesis of potassium 2-[2-(2-oxo-4-phenyl-2H-chromen-7-yloxy) acetyl]hydrazinecarbodithioate (3)
To a solution of 2-(2-oxo-4-phenyl-2H-chromen-7-yloxy)-acetohydrazide (2, 0.01 mol) in ethanol (30 mL), a solution of potassium hydroxide (0.01 mol) in water (5 mL) and carbon disulfide (0.01 mol) were added. The reaction mixture was heated under reflux for 3 h, the resulting solid on heating was collected by filtration, washed with ether and dried to afford 2.8 g of the potassium salt 3 (Scheme 1). Color: yellow. Yield: 90%. M.p.: >360 °C. FT-IR (KBr, ν, cm -1 ): 3320, 3266 (NH), 1698 (C=O). 1 
Synthesis of 7-[(5-thioxo-1,3,4-oxadiazol-2-yl)methoxy]-4-phenyl-2H-chromen-2-one (4)
The potassium salt 3 (0.01 mol) was dissolved in aqueous potassium hydroxide solution (0.01 mol) in water (10 mL) and refluxed for 2 h then cooled. The resulting reaction mixture was treated with dilute hydrochloric acid till pH=~4. The resulting solid was collected by filtration, washed with water, and recrystallized from ethanol to give compound 4 (Scheme 1 
Synthesis of 7-[(4-amino-5-thioxo-4, 5-dihydro-1H-1, 2, 4-triazol-3-yl) meth-oxy]-4-phenyl-2H-chromen-2-one (5)
Method A: To a solution of potassium salt 3 (0.01 mol) in ethanol (20 mL) and water (10 mL), hydrazine hydrate (0.2 mL) was added. The reaction mixture was heated under reflux for 2 h, then left to cool, then poured into crushed ice. The resulted reaction mixture was acidified with dilute hydrochloric acid.
Scheme 2
The resulting solid was collected by filtration, washed with water and recrystallized from dioxane (Scheme 1 Method B: A mixture of 7-[(5-thioxo-1,3,4-oxadiazol-2-yl)methoxy]-4-phenyl-2H-chromen-2-one (4) (0.01 mol) in ethanol (20 mL) and hydrazine hydrate (0.2 mL) was heated under reflux for 2 h, then left to cool and poured onto crushed ice. The reaction mixture was acidified with dilute hydrochloric acid till pH = ~4. The resulting solid was collected by filtration, washed with water and recrystallized from dioxane, to give compound 5.
Synthesis of N-(4-(4-nitrophenyl)-2-thioxothiazol-3(2H)-yl)-2-((2-oxo-4-phenyl-2H-chromen-7-yl)oxy) acetamide (7)
A mixture of potassium salt 3 (0.01 mol) and p-nitro phenacyl bromide (0.01 mol) in N,N-dimethylformamide (DMF) (15 mL) was heated under reflux for 3 h, then left to cool and poured onto crushed ice. The precipitated solid was collected by filtration, washed with ethanol, dried and recrystallized from dioxane (Scheme 1 
Synthesis of 7-{[5-(2-(4-nitrophenyl)-2-oxoethylthio)-1,3,4-oxadiazol-2-yl]methoxy}-4-phenyl-2H-chromen-2-one (8)
A mixture of 7-[(5-thioxo-1,3,4-oxadiazol-2-yl)methoxy]-4-phenyl-2H-chromen-2-one (4) (0.01 mol), p-nitrophenacyl bromide (0.01 mol) and anhydrous potassium carbonate (0.01 mol) in dry acetone (15 mL) was refluxed for 6 h. The formed precipitate was filtered off and washed with acetone. The filtrate was distilled under reduced pressure till dryness then the residue was treated with water. The solid formed was collected by filtration, washed with water, dried and recrystallized from dioxane to give compound 8 (Scheme 1). A mixture of 2-(2-oxo-4-phenyl-2H-chromen-7-yloxy)aceto hydrazide (2) (0.01 mol) and phthalic anhydride orpyrazine-2,3-dicarboxylic anhydride (0.01 mol) in glacial acetic acid (20 mL) was refluxed for 6 h, then the reaction mixture left to cool. The white solid was filtered off and recrystallized from dioxane to give compounds 13a,b (Scheme 3). 
N-(1,3-Dioxoisoindolin-2-yl)-2-(2-oxo-4-phenyl-2H-chromen-7-yloxy)-acetamide
N-(5,7-Dioxo-5H-pyrrolo[3,4-b]pyrazin-6(7H)-yl)-2-(2-oxo-4-phenyl-2H-chromen-7-yloxy)acetamide
General procedure for the preparation of 4-phenyl-7-((4-phenyl-5-substituted-4,5-dihydro-1H-1,2,4-triazol-3-yl) methoxy)-2H-chromen-2-one (15a,b)
A mixture of 2-(2-oxo-4-phenyl-2H-chromen-7-yloxy)aceto hydrazide (2) (0.01 mol) and phenylisothiocyanate or phenyliso-cyanate (0.01 mol) in dioxane (15 mL) was refluxed for3 h, the resulting solid on heating was collected by filtration, washed with ethanol several times and recrystallized from DMF to give compounds 15a,b (Scheme 3). 
4-Phenyl-7-((4-phenyl-5-thioxo-4,5-dihydro-1H-1,2,4-triazol-3-yl)methoxy)-2H-chromen-2-one
3-((2-Oxo-4-phenyl-2H-chromen-7-yloxy)methyl)-4-phenyl-1H-1,2,4-triazol-5(4H)-one
Synthesis of N'-(4-amino-5-cyano-6-(4-methoxy phenyl) pyrimidin-2-yl)-2-(2-oxo-4-phenyl-2H-chromen-7-yloxy) acetohydrazide (17)
A mixture of 2-(2-oxo-4-phenyl-2H-chromen-7-yloxy)aceto hydrazide (2) (0.01 mol),4-amino-2-mercapto-6-(4-methoxyphenyl)pyrimidine-5-carbonitrile (16) (0.01 mol) and pyridine (0.2 mL) in DMF (15 mL) was heated under reflux for 4 h, then left to cool and poured onto crushed ice. The reaction mixture was acidified with dilute hydrochloric acid till pH = ∼4. The resulting solid was collected by filtration, washed with water and recrystallized from dioxane (Scheme 3 
Synthesis of 7-[(6-benzyl-[1,2,4]triazolo[3,4-a] phthalazin-3-yl)methoxy]-4-phenyl-2H-chromen-2-one (20)
A mixture of 2-(2-oxo-4-phenyl-2H-chromen-7-yloxy) aceto hydrazide (2) (0.01 mol) and 4-benzyl-1-chlorophthalazine (18) (0.01 mol) in dry dioxane (10 mL) and a catalytic amount of pyridine was refluxed for 4 h. The solid product which obtained after cooling was collected and recrystallized from dioxane to give compound 20 (Scheme 4). 
Synthesis of 7-[(6-amino-4H-1,3,4-oxadiazin-2-yl) methoxy]-4-phenyl-2H-chromen-2-one (22)
A mixture of 2-(2-oxo-4-phenyl-2H-chromen-7-yloxy)aceto hydrazide (2) (0.01 mol) and chloroacetonitrile (0.01 mol) in dry dioxane (10 mL) and a catalytic amount of pyridine was refluxed for 3 h, then the reaction mixture left to cool. The solid product was filtered off, washed with ethanol several times and recrystallized from dioxane (Scheme 4 
Synthesis of 7-[(4,5-dihydro-1H-imidazol-2-yl) methoxy]-4-phenyl-2H-chromen-2-one (24)
A mixture of 2-(2-oxo-4-phenyl-2H-chromen-7-yloxy) acetic acid (23) 
General procedure for preparation of 7-(substituted-2-ylmethoxy)-4-phenyl-2H-chromen-2-one (25a-c)
A mixture of 2-(2-oxo-4-phenyl-2H-chromen-7-yloxy) acetic acid (23) (0.01 mol) and 1,2-phenylenediamine, or 2-aminophenol, or 2-aminothiophenol (0.01 mol) was heated without solvent at 180-200°C for 30 min. Then the mixture was left to cool. The solid products that formed were recrystallized from dioxane to give compounds 25a-c (Scheme 5). 
7-[(1H-Benzo[d]imidazol-2-yl)methoxy]-4-phenyl-2H-chromen-2-one
Synthesis of 2-(2-oxo-4-phenyl-2H-chromen-7-yloxy) acetyl chloride (26)
A mixture of 2-(2-oxo-4-phenyl-2H-chromen-7-yloxy)acetic acid (23) (0.01 mol) and thionyl chloride (15 mL) was fused for 1 h. Excess of thionyl chloride removed under pressure to obtain the pure acyl chloride (Scheme 5 A mixture of 2-(2-oxo-4-phenyl-2H-chromen-7-yloxy)acetyl chloride (26) (0.01 mol) and aniline derivatives namely (4-amino-acetophenone, 4-aminophenylacetic acid and 4-aminobenzoic acid) (0.01 mol) in dry dioxane (10 mL) and a catalytic amount of pyridine was refluxed for1 h, the resulting solid on heating was collected by filtration, washed with ethanol several times and recrystallized from DMF to give compounds 27a-c (Scheme 6). 
N-(4-Acetylphenyl)-2-(2-oxo-4-phenyl-2H-chromen-7-yloxy) acetamide
Synthesis of 4-[2-(2-oxo-4-phenyl-2H-chromen-7-yloxy)acetamido]benzenesulfonic acid (28)
A mixture of 2-(2-oxo-4-phenyl-2H-chromen-7-yloxy)acetyl chloride (26) (0.01 mol) and 4-aminobenzenesulfonic acid(0.01 mol) in dry dioxane (10 mL) and a catalytic amount of pyridine was refluxed for1 h, the resulting solid on heating was collected by filtration, washed with ethanol several times and recrystallized from DMF to give compound 28 (Scheme 6 
General procedure for preparation of 2-[2-(2-oxo-4-phenyl-2H-chromen-7-yloxy)acetamido] benzoic acid and Methyl-2-[2-(2-oxo-4-phenyl-2H-chromen-7-yloxy) acetamido] benzoate (29a,b)
A mixture of 2-(2-oxo-4-phenyl-2H-chromen-7-yloxy)acetyl chloride (26) (0.01 mol) and anthranilic acid or methyl anthranilate (0.01 mol) in dry dioxane (10 mL) and a catalytic amount of pyridine was refluxed for1 h, the resulting solid on heating was collected by filtration, washed with ethanol several times and recrystallized from DMF to give compounds 29a,b (Scheme 6). 
2-[2-(2-Oxo-4-phenyl-2H-chromen-7-yloxy)acetamido] benzoicacid
Synthesis of N,N'-bis [2-(2-oxo-4-phenyl-2H-chromen-7-yloxy) acetyl] hydrazine (30)
A mixture of 2-(2-oxo-4-phenyl-2H-chromen-7-yloxy) acetyl chloride (26) (0.01 mol) and 2-(2-oxo-4-phenyl-2H-chromen-7-yloxy) acetohydrazide (2) (0.01 mol) in dry dioxane (10 mL) and a catalytic amount of pyridine was refluxed for 2 h. 
General procedure for preparation of N-{4-[N-(substituted) sulfamoyl] phenyl}-2-(2-oxo-4-phenyl-2H-chromen-7-yloxy) acetamide (31a,b).
A mixture of 2-(2-oxo-4-phenyl-2H-chromen-7-yloxy) acetyl chloride (26) (0.01 mol) and benzenesulfonamide derivatives namely (4-amino-N-(5-methylisoxazol-3-yl) benzene sulfonamide and 4-amino-N-(2,6-dimethoxy pyrimidin-4-yl)benzenesulfonamide) (0.01 mol) in dry dioxane (10 mL) and a catalytic amount of pyridine was refluxed for1 h. Then the mixture was left to cool. The solid product that formed was recrystallized from dioxane to give compounds 31a,b (Scheme 6). 
N-{4-[N-(5-Methylisoxazol-3-yl)sulfamoyl]phenyl}-2-(2-oxo-4-phenyl-2H-chromen-7-yloxy)acetamide
N-{4-[N-(2,6-Dimethoxypyrimidin-4-yl)sulfamoyl]phenyl}-2-(2-oxo-4-phenyl-2H-chromen-7-yloxy)acetamide
General procedure for preparation of N,N'-bis[2-(2-oxo-4-phenyl-2H-chromen-7-yloxy)acetyl]p-phenylene diamine, N,N'-bis[2-(2-oxo-4-phenyl-2H-chromen-7-yloxy) acetyl] benzidine, N,N'-bis[2-(2-oxo-4-phenyl-2H-chromen-7-yloxy) acetyl]ethylenediamine and N,N'-bis[2-(2-oxo-4-phenyl-2H-chromen-7-yloxy)acetyl]4-aminobenzenesulfonamide (32a-d)
A mixture of 2-(2-oxo-4-phenyl-2H-chromen-7-yloxy)acetyl chloride (26) (0.02 mol) and bifunctional amines namely (1,4-phenylenediamine, benzidine, ethylenediamine and 4-aminoben-zenesulfonamide) (0.01 mol) in dry dioxane (10 mL) and a catalytic amount of pyridine was refluxed for2 h. The precipitate formed was filtered off hot, washed with ethanol several times, dried and recrystallized from DMF to give compounds 32a-d (Scheme 7) . 
N,N'-bis[2-(2-Oxo-4-phenyl-2H-chromen-7-yloxy)acetyl]pphenylene-diamine
Pharmacology
2,2-Diphenyl-1-picrylhydrazyl (DPPH) radical scavenging activity
In the DPPH assay, antioxidants reduce the free radical 2,2-diphenyl-1-picrylhydrazyl. In the presence of an antioxidant, the purple color of DPPH • fades and the change of absorbance can be followed spectrophotometrically at 515 nm [27] .
Test compounds are dissolved in N,N-dimethylformamide (DMF) solution to specific concentrations, and each sample was mixed with DPPH in DMF solution, the blank sample contains the same amount of DMF and DPPH. The mixtures were left for 15 min at 25 °C then the absorbance measured at 517 nm using the UV-vis spectrophotometer. Generally, the results are reported as the percent of inhibition, i.e. the amount of antioxidant necessary to decrease the initial DPPH • concentration by 50%. The percentage of DPPH radical scavenger was calculated using the equation (1), [28] .
The percentage of DPPH radical scavenger = [(A0-At)/A0]×100 ( 1 ) Where, A0 is the absorbance value of blank sample, at a particular time and At is the absorbance value of the tested sample. The IC50 (concentration causing 50% inhibition of DPPH) values of each test compound are determined. Ascorbic acid can be used as positive controls.
Cytotoxicity assay in-vitro
The cytotoxicity of the drugs will be tested against human liver cancer cell line (HepG2) by SRB assay as described by Sumangala et al. [29] . Exponentially growing cells will be collected using 0.25% Trypsin-EDTA and plated in 96-well plates at 1000-2000 cells/well. Cells will be exposed to the drugs for 72 h and subsequently fixed with TCA (10%) for 1 h at 4 °C. After several washings, cells will be exposed to 0.4% SRB solution for 10 min in dark place and subsequently washed with 1% glacial acetic acid. After drying overnight, Tris-HCl will be used to dissolve the SRB-stained cells and color intensity will be measured at 492 and 630 nm (for the reference wavelength) with the enzyme linked immune sorbent assay (ELISA) reader. All of the compounds were tested in twice in each of the cell lines.
Results and discussion
Synthesis
Hydrazinolysis of ethyl 2-(2-oxo-4-phenyl-2H-chromen-7-yloxy)acetate (1)with hydrazine hydrate in ethanol at refluxing temperature,2-(2-oxo-4-phenyl-2H-chromen-7-yloxy)aceto hydrazide (2) Condensation of 7-[(4-amino-5-thioxo-4,5-dihydro-1H-1,2, 4-triazol-3-yl)methoxy]-4-phenyl-2H-chromen-2-one(5)with 4-nitrobenzaldehyde in refluxing ethanol containing a few drops from acetic acid gave the corresponding imine 11, rather than the expected product triazolothiadiazolyl derivative12, (Scheme 2). Also, the acetohydrazide2 was reacted with some anhydrides such as phthalic anhydride and pyrazine-2,3-dicarboxylicanhydride in refluxing glacial acetic acid to give the corresponding imides which formulated as N-(substituted)-2-(2-oxo-4-phenyl-2H-chromen-7-yloxy)acetamide (13a,b), respectively. Treatment of compound 2 with phenylisothio cyanate and phenylisocyanate in refluxing dioxane gave 4-phenyl-7-[(4-phenyl-5-thioxo-4,5-dihydro-1H-1,2,4-triazol-3-yl)methoxy]-2H-chromen-2-one (15a) and 3-[(2-oxo-4-phenyl-2H-chromen-7-yloxy)methyl]-4-phenyl-1H-1,2,4-triazol-5(4H)-one (15b), respectively. The formation of these compounds were assumed to proceed via nucleophilic addition of amino group in compound 2 to isothiocyanate and/or isocyanate to give acyclic non-isolable semicarbazide intermediate 14a,b which underwent intramolecular cyclization by elimination of water molecule to furnish the final products 15a,b, respectively. Acetohydrazide 2 reacted with 4-amino-2-mercapto-6-(4-methoxyphenyl) pyrimidine-5-carbonitrile (16) [30] in refluxing DMF in the presence of a few drops from pyridine to give N'- [4-amino-5-cyano-6-(4-methoxyphenyl) pyrimidin-2-yl]-2-(2-oxo-4-phenyl-2H-chromen-7-yloxy)aceto hydrazide (17) , (Scheme 3).
The reaction of hydrazide2 with 4-benzyl-1-chloro phthalazine (18) [31] (20) as the only isolable product. The formation of this compound was explained by the nucleophilic transformation into acyclic nonisolable intermediate 19 which undergoes intramolecular ring closure to the final product via elimination of water molecule, while treatment of hydrazide2 with chloroacetonitrile in dry dioxane-pyridine under reflux yielded a product which identified as 7-[(6-amino-4H-1,3,4-oxadiazin-2-yl)methoxy]-4-phenyl-2H-chromen-2-one (22) . The formation of this compound was assumed by nucleophilic substitution to form acyclic non-isolable intermediate 21 followed by intramolecular attack at the cyanide group to form the cyclized product 22 (Scheme 4).
On the other hand, when ethyl 2-(2-oxo-4-phenyl-2H-chromen-7-yloxy)acetate (1) was treated with sodium hydroxide in refluxing ethanol yielded the corresponding acid which identified as 2-(2-oxo-4-phenyl-2H-chromen-7-yloxy)acetic acid (23) [26] .
7-((4,5-Dihydro-1H-imidazol-2-yl)methoxy)-4-phenyl-2H-chromen-2-one (24) was prepared by fusion of ethylene diamine with compound 23, while cyclocondensation of compound 23 with (1,2-phenylenediamine, 2-aminophenol and 2-aminothiophenol) under fusion conditions yielded products which identified as 7-[(substituted)methoxy]-4-phenyl-2H-chromen-2-one (25a-c). Treatment of compound 23 with thionyl chloride gave the corresponding acid chloride as 2-(2-oxo-4-phenyl-2H-chromen-7-yloxy) acetyl chloride (26) (Scheme 5).
The acid chloride 26 was allowed to react with different aromatic amines in dry dioxane containing a few drops of pyridine under reflux afforded products which identified as: N-(4-acetylphenyl)-2-(2-oxo-4-phenyl-2H-chromen-7-yloxy) acetamide (27a), 2-{4-[2-(2-oxo-4-phenyl-2H-chromen-7-yloxy)acetamido]-phenyl}acetic acid (27b) and 4-[2-(2-oxo-4-phenyl-2H-chromen-7-yloxy)acetamido]benzoic acid (27c), respectively. Furthermore, whencompound 26 was subjected to the reaction with 4-amino benzenesulfonic acid in refluxing dioxane-pyridine yielded asingle product which identified as: 4-[2-(2-oxo-4-phenyl-2H-chromen-7-yloxy)acetamido] benzenesulfonic acid (28) , while compound 26 reacted with anthranilic acid and methyl anthranilate in boiling dioxanepyridineto give the products which were found to be 2-[2-(2-oxo-4-phenyl-2H-chromen-7-yloxy)acetamido] benzoic acid (29a) and methyl 2-[2-(2-oxo-4-phenyl-2H-chromen-7-yloxy) acetamido]benzoate (29b), respectively. Also, reaction of acid chloride 26 with 2-(2-oxo-4-phenyl-2H-chromen-7-yloxy) acetohydrazide (2) in dry dioxane containing a few drops from pyridine at reflux temperature afforded bis acyl hydrazine derivative 30. The acid chloride 26 was reacted with sulfa drug derivatives under the same reaction conditions to produce N-{4-[N-(substituted)sulfamoyl] phenyl}-2-(2-oxo-4-phenyl-2H-chromen-7-yloxy)acetamide (31a,b) (Scheme 6).
Finally, this investigation was extended to include the reactivity of 2-(2-oxo-4-phenyl-2H-chromen-7-yloxy)acetyl chloride (26) towards bifunctional isolated amines to furnish the corresponding bis compounds (32a-d) (Scheme 7).
Pharmacology
Antioxidant activity
Antioxidant compounds in food play an important role as a health-protecting factor. Scientific evidence suggests that antioxidants reduce the risk for chronic diseases. The role of antioxidant is to remove free radicals, by donating hydrogen to free radicals in its reduction to produce non-reactive species.
Many synthetic antioxidant compounds have shown toxic and/or mutagenic effects; therefore attention has been paid to naturally occurring antioxidants. Test compounds were screened for in vitro antioxidant activity using DPPH.
The effect of the different synthetic compounds on DPPH radical scavenging was compared to ascorbic acid using as positive control and appreciated by the determination of the IC50 values. The results are listed in Table 1. DPPH test is a direct and reliable method for determining radical scavenging action. The DPPH radical contains an odd electron, which is responsible for the absorbance at 515-517 nm and also for a visible deep purple color. When DPPH accepts an electron donated by an antioxidant compound, the DPPH is decolorized, which can be quantitatively measured from the changes in absorbance.
The ratio of antioxidant/DPPH required to decrease the concentration of DPPH to 50% of its initial value, denoted as IC50 or Efficient Concentration (EC50), is an indicator of antiradical activity [32] . It is clear from the tabulated results that compound 10showed the best antioxidant activity against DPPH intested compounds, while compounds 29b, 31a and 32a showed no activity. In concentration 1000 μg/mL, we noted that derivative 10 has most potent scavenging behavior among test compounds and also more potent than ascorbic acid. Similarly, 28 and 32b have scavenging activity more than ascorbic acid (Figure 1 ). However, compound 4 have scavenging activity similar to ascorbic acid. 
Cytotoxicity assay in vitro
The results expressed as IC50 (inhibitory concentration of 50%) were the averages of two determinations and were calculated by using igmoidal concentration-response curve fitting models (Sigma Plot software). The results are listed in Table 2 .
This study revealed that 7-{[6-(4-nitrophenyl)-7H- 
